Low abundance of sweat duct Cl- channel CFTR in both healthy and cystic fibrosis athletes with exceptionally salty sweat during exercise

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 300, Issue 3, 2011, Pages

  Brown, Mary Beth ^a   Haack, Karla K V ^b   Pollack, Brian P ^c   Millard Stafford, Mindy ^a   McCarty, Nael A ^b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EMORY UNIVERSITY   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Eccrine; Epithelial sodium channel; Heat; Sodium; Sweat gland; Thermoregulation

Indexed keywords

ALDOSTERONE; AQUAPORIN 5; CHLORIDE; CHLORIDE CHANNEL; POTASSIUM CHANNEL; SODIUM CHANNEL; SODIUM CHLORIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR; VASOPRESSIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; ATHLETE; CELL MEMBRANE; CHLORIDE TRANSPORT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYSTIC FIBROSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTROLYTE BLOOD LEVEL; EXERCISE; FEMALE; GENE MUTATION; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SALTY SWEAT; SWEAT GLAND; SWEAT GLAND DISEASE; THERMOREGULATION; UNITED STATES; VASOPRESSIN BLOOD LEVEL;

ADULT; ALDOSTERONE; AQUAPORIN 5; BICYCLING; BIOPSY; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; EPITHELIAL SODIUM CHANNEL; EXERCISE; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC PREDISPOSITION TO DISEASE; HOT TEMPERATURE; HUMANS; KINETICS; MUTATION; NEUROPHYSINS; PHENOTYPE; PROTEIN PRECURSORS; SODIUM CHLORIDE; SWEAT; SWEAT GLANDS; SWEATING; VASOPRESSINS; YOUNG ADULT;

EID: 79954464955     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00660.2010     Document Type: Article

References (85)

1. ACOG. American College of Obstetricians and Gynecologist (ACOG) commitee opinion: Update on carrier screening for cystic fibrosis. Obstet Gynecol 106: 1465-1468, 2005.
2. Alfaidy N, Blot-Chabaud M, Bonvalet JP, Farman N. Vasopressin potentiates mineralocorticoid selectivity by stimulating 11 beta hydroxysteroid deshydrogenase in rat collecting duct. J Clin Invest 100: 2437-2442, 1997.
3. Allan JR, Wilson CG. Influence of acclimatization on sweat sodium concentration. J Appl Physiol 30: 708-712, 1971.
4. Andersen LJ, Andersen JL, Schutten HJ, Warberg J, Bie P. Antidiuretic effect of subnormal levels of arginine vasopressin in normal humans. Am J Physiol Regul Integr Comp Physiol 259: R53-R60, 1990.
5. Armstrong L, Maresh C, Castellani J, Bergeron M, Kenefick R, La Gasse K, Riebe D. Urinary indices of hydration status. Int J Sport Nutr Exerc Metab 4: 265-279, 1994.
6. Bankir L, Niesor R, Bouby N. Sodium excretion is impaired by high urinary concentration. FASEB J 9: A5, 1995.
7. - permeability on sweating in cystic fibrosis. Am J Physiol Cell Physiol 247: C3-C9, 1984.
8. Brisson GR. A simple and disposable sweat collector. Eur J Appl Physiol 63: 269-272, 1991.
9. + channel in the collecting duct by vasopressin contributes to water reabsorption. Am J Physiol Renal Physiol 297: F1411-F1418, 2009.
10. Burghardt B, Elkaer M, Kwon T, Rácz G, Varga G, Steward M, Nielsen S. Distribution of aquaporin water channels AQP1 and AQP5 in the ductal system of the human pancreas. Gut 52: 1008-1016, 2003.
11. Burghardt B, Elkjaer ML, Kwon TH, Racz G, Varga G, Steward MC, Nielsen S. Distribution of aquaporin water channels AQP1 and AQP5 in the ductal system of the human pancreas. Gut 52: 1008-1016, 2003.
12. Butterworth MB, Edinger RS, Frizzell RA, Johnson JP. Regulation of the epithelial sodium channel by membrane trafficking. Am J Physiol Renal Physiol 296: F10-F24, 2009.
13. Campese V, Park J. The kidney and hypertension: over 70 years of research. J Nephrol 19: 691-698, 2006.
14. Cheng S, Gregory R, Marshall J, Paul S, Souza D, White G, O'Riordan C, Smith A. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63: 827-834, 1990.
15. Choukroun G, Schmitt F, Martinez F, Drueke TB, Bankir L. Low urine flow reduces the capacity to excrete a sodium load in humans. Am J Physiol Regul Integr Comp Physiol 273: R1726-R1733, 1997.
16. Claass A, Sommer M, de Jonge H, Kalin N, Tummler B. Applicability of different antibodies for immunohistochemical localization of CFTR in sweat glands from healthy controls and from patients with cystic fibrosis. J Histochem Cytochem 48: 831-837, 2000.
17. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339: 653-658, 1998.
18. Cohn JA, Melhus O, Page LJ, Dittrich KL, Vigna SR. CFTR: Development of high-affinity antibodies and localization in sweat gland. Biochem Biophys Res Commun 181: 36, 1991.
19. Crawford I, PM, PZ, Guggino WB, Hyde S, Turley H, Gatter K, Harrie A, Higgins C. Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci USA 88: 9262-9266, 1991.
20. Cuthbert AW, Halstead J, Ratcliff R, Colledge WH, Evans MJ. The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study. J Physiol 482: 449-454, 1995.
21. Cutting GR. Cystic Fibrosis Mutation Database, http://www.genet. sickkids.on.ca/Home.html, 2009.
22. Dalemans W, Barbry P, Champigny G, Jallat S, Dott K, Dreyer D, Crystal RG, Pavirani A, Lecocq JP, Lazdunski M. Altered chloride ion channel kinetics associated with the [Delta]F508 cystic fibrosis mutation. Nature 354: 526-528, 1991.
23. Davis PB. Molecular and cell biology of cystic fibrosis. J Appl Physiol 70: 2331-2333, 1991.
24. Deen P, Verdijk M, Knoers N, Wieringa B, Monnens L, van Os C, van Oost B. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264: 92-95, 1994.
25. Eduardo P, David AC. Primary aldosteronism: Diagnosis and treatment. J Clin Hypertens 8: 887-893, 2006.
26. Eichner E. Genetic and other determinants of sweat sodium. Curr Sports Med Rep 7: S36-S40, 2008.
27. Fasciolo JC, Totel GL, Johnson RE. Antidiuretic hormone and human eccrine sweating. J Appl Physiol 27: 303-307, 1969.
28. Fava C, von Wowern F, Berglund G, Carlson J, Hedblad B, Rosberg L, Burri P, Almgren P, Melander O. 24-h ambulatory blood pressure is linked to chromosome 18q21-22 and genetic variation of NEDD4L associates with cross-sectional and longitudinal blood pressure in Swedes. Kidney Int 70: 562-569, 2006.
29. Gambling L, Dunford S, Wilson CA, McArdle HJ, Baines DL. Estrogen and progesterone regulate α, β, and γNaC subunit mRNA levels in female rat kidney. Kidney Int 65: 1774-1781, 2004.
30. Gresz V, Kwon TH, Gong H, Agre P, Steward MC, King LS, Nielsen S. Immunolocalization of AQP-5 in rat parotid and submandibular salivary glands after stimulation or inhibition of secretion in vivo. Am J Physiol Gastrointest Liver Physiol 287: G151-G161, 2004.
31. Hew-Butler TD, Noakes TD, Soldin SJ, Verbalis JG. Acute changes in arginine vasopressin, sweat, urine and serum sodium concentrations in exercising humans: Does a coordinated homeostatic relationship exist? Br J Sports Med 44: 710-715, 2010.
32. Hirasawa G, Sasano H, Takahashi Ki Fukushima K, Suzuki T, Hiwatashi N, Toyota T, Krozowski ZS, Nagura H. Colocalization of 11β-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human epithelia. J Clin Endocrinol Metab 82: 3859-3863, 1997.
33. Kabashima K, Shimauchi T, Kobayashi M, Fukamachi S, Kawakami C, Ogata M, Kabashima R, Mori T, Ota T, Fukushima S, Hara-Chikuma M, Tokura Y. Aberrant aquaporin 5 expression in the sweat gland in aquagenic wrinkling of the palms. J Am Acad Dermatol 59: S28-S32, 2008.
34. Kalin N, Claabeta A, Sommer M, Puchelle E, Tummler B. DeltaF508 CFTR expression in tissues from patients with cystic fibrosis. J Clin Invest 103: 1379-1386, 1999.
35. Karnter N, Augustinas O, Jensen T, Naismith L, Riordin J. Mislocalization of deltaF508 CFTR in cystic fibrosis sweat gland. Nat Genet 1: 321-327, 1992.
36. Kreda SM, Gynn MC, Fenstermacher DA, Boucher RC, Gabriel SE. Expression and localization of epithelial aquaporins in the adult human lung. Am J Respir Cell Mol Biol 24: 224-234, 2001.
37. Kunzelmann K, Schreiber J. CFTR, a regulator of channels. J Membr Biol 168: 1-8, 1999.
38. Lemon P, Yarasheski K, Dolny D. Validity/reliability of sweat analysis by whole body washdown vs. regional collections. J Appl Physiol 61: 1967-1971, 1986.
39. Lieberman J, Kellog F. Evaluation of the sweat chloride asay in adults: use of pilocarpine iontophoresis. Am J Med Sci 246: 537-549, 1963.
40. Lukacs GL, Chang XB, Bear C, Kartner N, Mohamed A, Riordan JR, Grinstein S. The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J Biol Chem 268: 21592-21598, 1993.
41. Machado-Moreira C, Smith F, van den Heuvel A, Mekjavic I, Taylor N. Sweat secretion from the torso during passively-induced and exerciserelated hyperthermia. Eur J Appl Physiol 104: 265-270, 2008.
42. Montain S, Cheuvront SN, Lukaski H. Sweat mineral element responses during 7 hr of exercise-heat stress. Int J Sport Nutr Exerc Metab 17: 574-582, 2007.
43. Montain SJ, Cheuvront SN, Sawka MN. Exercise associated hyponatremia: quantitative analysis to understand the aetiology. Br J Sports Med 40: 98-106, 2006.
44. Montain SJ, Sawka M, Wenger C. Hyponatremia associated with exercise: risk factors and pathogenesis. Exerc Sport Sci Rev 29: 113-117, 2001.
45. Morgan R, Patterson M, Nimmo M. Acute effects of dehydration on sweat composition in men during prolonged exercise in the heat. Acta Physiol Scand 182: 37-43, 2004.
46. Nejsum LN, Kwon TH, Jensen UB, Fumagalli O, Frokiaer J, Krane CM, Menon AG, King LS, Agre PC, Nielsen S. Functional requirement of aquaporin-5 in plasma membranes of sweat glands. Proc Natl Acad Sci USA 99: 511-516, 2002.
47. Nicco C, Wittner M, DiStefano A, Jounier S, Bankir L, Bouby N. Chronic exposure to vasopressin upregulates γNaC and sodium transport in the rat renal collecting duct and lung. Hypertension 38: 1143-1149, 2001.
48. Noakes TD, Sharwood K, Speedy D, Hew T, Reid S, Dugas J, Almond C, Wharam P, Weschler L. Three independent biological mechanisms cause exercise-associated hyponatremia: Evidence from 2,135 weighed competitive athletic performances. Proc Natl Acad Sci 102: 18550-18555, 2005.
49. Orenstein DM, Henke KG, Green CG. Heat acclimation in cystic fibrosis. J Appl Physiol 57: 408-412, 1984.
50. Pahnke M. Large interindividual variability in sweat sodium loss in well-trained endurance athletes. In: American College of Sports Medicine 53rd Annual Meeting. Indianapolis, IN: American College of Sports Medicine, 2006.
51. Patterson MJ. Variations in regional sweat composition in normal human males. Exp Physiol 85: 869-875, 2000.
52. Qing W, Jean-Daniel H, Marc M, Hans RB, Bernard CR, Michel B. Salt-and angiotensin II-dependent variations in amiloride-sensitive rectal potential difference in mice. Clin Exp Pharma Physiol 27: 60-66, 2000.
53. Quinton PM. Cystic fibrosis: a disease in electrolyte transport. FASEB J 4: 2709-2717, 1990.
54. Quinton PM. Cystic fibrosis: Lessons from the sweat gland. Physiology 22: 212-225, 2007.
55. Quinton PM. Effects of some ion transport inhibitors on secretion and rabsorption in intact and perfused single human sweat glands. Pflügers Arch 391: 303-313, 1981.
56. Quinton PM. What is good about cystic fibrosis? Current Biology 4: 742-743, 1994.
57. Quinton PM, Bijman J. Higher bioelectric potentials due to decreased chloride absorption in the sweat glands of patients with cystic fibrosis. N Engl J Med 308: 1185-1189, 1983.
58. Raman V, Clary R, Siegrist K, Zehnbauer B, Chatila T. Increased prevalence of mutations in the cystic fibrosis transmembrane conductance regulator in children with chronic rhinosinusitis. Pediatrics 109: E13, 2002.
59. - channel function. Nature 402: 301-304, 1999.
60. Reddy MM, Quinton PM. cAMP activation of CF-affected Cl-conductance in both cell membranes of an absorpive epithelium. J Membr Biol 130: 49-62, 1992.
61. Reddy MM, Quinton PM. Functional interaction of CFTR and γNaC in sweat glands. Pflügers Arch 445: 499-503, 2003.
62. Reddy MM, Quinton PM. Localization of Cl-conductance in normal and Cl-impermeability in cystic fibrosis sweat duct epithelium. Am J Physiol Cell Physiol 257: C727-C735, 1989.
63. Rosner MH, Kirven J. Exercise-associated hyponatremia. Clin J Am Soc Nephrol 2: 151-161, 2007.
64. Rowntree R, Harris A. The phenotypic consequences of CFTR mutations. Annals Human Genet 67: 2003.
65. Sato K, Freibleman C, Dobson R. The electrolyte composition of pharmacologically and thermally induced sweat: a comparative study. J Invest Dermatol 55: 1970.
66. Sato K, Kang W, Saga K, Sato T. Biology of the eccrine sweat gland. I. Mechanism of sweat secretion. J Am Acad Dermatol 20: 537-563, 1989.
67. Sato K, Sato F. Methods for studying eccrine sweat gland function in vivo and in vitro. Methods Enzymol 192: 583-599, 1990.
68. + concentrations in cystic fibrosis eccrine sweat in vivo and in vitro. J Lab Clin Med 115: 504-511, 1990.
69. Sauter D, Fernandes S, Goncalves-Mendes N, Boulkroun S, Bankir L, Loffing J, Bouby N. Long-term effects of vasopressin on the subcellular localization of γNaC in the renal collecting system. Kidney Int 69: 1024-1032, 2006.
70. Sawka M, Burke L, Eichner E, Maughan R, Montain S, Stachenfeld N. American College of Sports Medicine position stand. Exercise and fluid replacement. Med Sci Sports Exerc 39: 377-390, 2007.
71. Schafer JA. Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct. Am J Physiol Renal Physiol 283: F221-F235, 2002.
72. Schulz I. Micropuncture studies of the sweat formation in cystic fibrosis patients. J Clin Invest 48: 1470-1477, 1969.
73. Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339: 645-652, 1998.
74. Shirreffs SM, Maughan RJ. Whole body sweat collection in humans: an improved method with preliminary data on electrolyte content. J Appl Physiol 82: 336-341, 1997.
75. Shwachman H, Mahmoodian A. Pilocarpine iontophoresis sweat testing results of seven years' experience. Mod Probl Pediat 10: 158-182, 1966.
76. Shwachman H, Mahmoodian A, Neff RK. The sweat test: Sodium and chloride values. J Pediatr 98: 576, 1981.
77. Siegel AJ, Verbalis JG, Clement S, Mendelson JH, Mello NK, Adner M, Shirey T, Glowacki J, Lee-Lewandrowski E, Lewandrowski KB. Hyponatremia in marathon runners due to inappropriate arginine vasopressin secretion. Am J Med 120: 461. e411-461. e417, 2007.
78. Song Y, Sonawane N, Verkman A. Localization of aquaporin-5 in sweat glands and functional analysis using knockout mice. J Physiol 541: 561-568, 2002.
79. Song Y, Verkman A. Aquaporin-5 dependent fluid secretion in airway submucosal cells. J Biol Chem 276: 41288-41292, 2001.
80. Speedy D, Rogers I, Noakes T, Wright S, Thompson J, Campbell R, Hellemans I, Kimber N, Boswell D, Kuttner J, Safih S. Exerciseinduced hyponatremia in ultradistance athletes is caused by inappropriate fluid retention. Clin J Sport Med 10: 272-278, 2000.
81. Stutts MJ, Canessa CM, Olson JC, Hamrick M, Cohn J, Rossier BC, Boucher RC. CFTR as a cAMP-dependent regulator of sodium channels. Science 269: 847-850, 1995.
82. Vimieiro-Gomes AC, Magalhaes FC, Amorim FT, Machado-Moreira CA, Rosa MS, Lima NV, Rodrigues LC. Comparison of sweat rate during graded exercise and the local rate induced by pilocarpine. Braz. J. Med. Biol. Res. 38: 1133-1139, 2005.
83. Wang X, Moylan B, Leopold DA, Kim J, Rubenstein RC, Togias A, Proud D, Zeitlin PL, Cutting GR. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA 284: 1814-1819, 2000.
84. Weschler LB. Sweat electrolyte concentrations obtained from within occlusive coverings are falsely high because sweat itself leaches skin electrolytes. J Appl Physiol 105: 1376-1377, 2008.
85. Ziedalski TM, Kao PN, Henig NR, Jacobs SS, Ruoss SJ. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. Chest 130: 995-1002, 2006.